Blogger
Help
Send feedback
Sign in
Blogger
Employee News Week 2
On Blogger since: September 2008
Profile views: 106
Report Abuse
My blogs
FDA Inspection Growth In China Stymied By Visa Issues
US acquirers cut taxes by relocating to Europe after mergers
PM overrules DIPP, HealthMin to clear Mylan's Strides deal
India running out of tuberculosis and Aids medicines
Quality Problems Mount for Wockhardt with UK Drug Recall
Actavis’ Bioequivalence Data Still Missing For Bupropion XL
Which US Tuna Brand Is Most American? What Did You Think?
A Changed Biotech Sector Draws Fans
Novartis Starts Investigation On China Bribery Allegations; SAIC Initiates Crackdown On Illegal
Harbert calls for U.S. to become united on energy
Electronic Labeling Study By GAO Yields “No Consensus,” Avoids Cost Issue
India Drug Makers Struggle To Follow Lupin Into Japan's Generics Market
GDUFA: Fee Avoidance Affects Rates Again
Will New Merger Boost Gains For Drug Maker Actavis?
Seven Nations Join Forces To Keep Eye On Exploding Generics Market
FDA to Allow Generic Drugmakers to Make Label Changes Independent of Innovators
China Gives Conditional Clearance To $4 Billion Baxter-Gambro Merger
India Parliament Committee Urges End To FDI In Existing Domestic Drug Makers
Europe Renews Innovative Medicines Initiative, With Funding Boost
China Public Security Ministry Claims Evidence Of GSK Bribery; Several Execs Arrested
GPhA Battles State Biosimilar Bills; 5 Passed, 10 Rejected
Xinhua Opinion: Focus On Hospital Reforms To Lower China Drug Costs
Billion-Dollar Savings From Biosimilar Versions of Popular Brand-name Biologics Projected
Indian firms struggle to crack world's second-largest drug market
A double Aids breakthrough; Business Commentary
California Court Rules Unlicensed School Staff Can Give Insulin
China widens probe into drug pricing and corruption
Electronic Labeling Study By GAO Yields “No Consensus,” Avoids Cost Issue
FDA Opens the Door for Metadate ER Generics
Avanir Settles With Sandoz Over Nuedexta Generic Plans
Mylan Ducks $15M Bristol-Myers Contract Suit Over HIV Drug
Mylan Acquisition Of India's Agila Could Get Government Approval Soon
Probe Of Sanofi Launched As China Gets Handle On Nagging Drug Prices
Mylan Confirms First-to-File Patent Challenge Relating to CANASA
HHS and U. of Illinois Sue Lupin for Patent Infringement
First-In-Class Drugs Are True Barometer Of Industry Innovation, FDA Says
Generic Rx Shortage Initiative Stuck: Too Few Manufacturers To Pick Up Slack
Mylan Acquisition Of India's Agila Could Get Government Approval Soon
New system follows rise in cost of drugs
Taiwan Looks To Generic Savings In HIV Drug Reimbursement To Build On Multinational Price Cuts
Novartis Sales Rep Says Ordered To Bribe China Doctors For Drug Sales
Senate Floats Bipartisan FDA User Fee Security Bill
China Outlines Ambitious Roadmap To Clean Up Clinical Data Quality
GSK subsidiary wins watchdog approval for HIV treatment
U.K. Recalls Drugs Made in India
India’s Sun Pharma Reviews Global Targets While Close Competitor Cipla Eyes Gains From Expansion
Pharmaceutical Companies; Mylan Launches Generic Version of Viagra(R) in 11 European Countries
Whose Burden Is It Anyway? REMS’ Health Care Impact Belongs To FDA, PhRMA Says
Seven Nations Join Forces To Keep Eye On Exploding Generics Market
Generic Share Reaches 25.8% by Volume, 10.5% by Price in FY2012: JGA
The Worlds Most Innovative Companies
UPDATE: House panel for complete ban on takeovers of large domestic drugmakers by MNCs
China Outlines Ambitious Roadmap To Clean Up Clinical Data Quality
Judge tosses Bristol-Myers contract claim over AIDS drug; FROM THE COURTS
Comparing drug prices across borders a difficult task
Sanofi Sees Emerging Market Led By China The Second Largest Insulin Opportunity After U.S.
China Agency Launches Three-Month Probe Of Bribery Allegations
Appeals Court Upholds Five Mylan Patents for Perforomist
New Rules Slow Pharmaceutical Trials in India
FDA Approves HIV Drug from ViiV Collaborative Drug Development
StarKist Ranch Single Serve Tuna Creations Launch
Paying to delay generic drugs
Kansas native brings pit BBQ to Morgantown
County's future shines bright; Guest Editorial
Generic Rx Shortage Initiative Stuck: Too Few Manufacturers To Pick Up Slack
Generic Companies Gain Little From FDA Decision On Access To REMS Drugs
Delays on generics are costly for consumers, report finds
IMS Study Says Patent Settlements Have Saved $25.5 Billion Since 2005
Novartis Hit by Scandal Over Japanese Drug Studies
After A Brief Pause, Injectables Cash Cow Agila Is Back Into Production
Many Of China's 9 Million Epileptics Lack Sufficient Medical Resources
FDA Opens the Door for Metadate ER Generics
Starkist ads back
Aussie Groups Say Pharmacies Add Charges That Eclipse Drug Price Cuts
BUSINESS
After A Brief Pause, Injectables Cash Cow Agila Is Back Into Production; Pfizer Expects Shipping
Generic Industry Needs to Produce 30 Billion More Tablets to Meet 60% Generic Share Goal
EU Pharma Wants API Manufacturing Compliance Waivers As Foreign Shortages Loom
Louisiana, Watson Pharmaceuticals Reach $8.5 Million Settlement in Rx Pricing Case
Adcock Says $1.3 Billion Acquisition Talks Remain Exclusive To CFR
Prestige buys Sydney's Care Pharma
Unresolved issues with global drug regulators to hit Wockhardt's performance
PM Vetoes DIPP, Health Min to Clear the Way for Pharma FDI
China steps up its scrutiny of western drugs prices
Starkist ads back
Bart Rauluk's 50th Birthday Party
Mylan Classic Tees Off
Supreme Court Remands Pay-For-Delay Settlement For Antitrust Review In FTC v. Actavis
Surprise! Roche Says It Will Not Pursue Herceptin Patents In India
Taking A Selective Tack In Developing Generics Actavis focuses on new ways to deliver patented drugs
U.S. Sentences British Citizen for Distributing Fake Avastin
Sun Pharma to sell Prandin generic in US with six-month exclusivity
Amgen Sues Teva to Block Sales of Lipegfilgrastim
China accuses GSK of bribing officials
About me
